Literature DB >> 29524149

Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.

Sumiyo Morita1, Takuro Horii1, Izuho Hatada2.   

Abstract

DNA methylation, one of the most studied epigenetic modifications, regulates many biological processes. Dysregulation of DNA methylation is implicated in the etiology of several diseases, such as cancer and imprinting diseases. Accordingly, technologies designed to manipulate DNA methylation at specific loci are very important, and many epigenome editing technologies have been developed, based on zinc finger proteins, TALEs, and CRISPR/dCas9 targeting. We describe a protocol to induce and assess DNA demethylation on a target gene. It is based on a modification of the dCas9-SunTag system for efficient, targeted demethylation at specific DNA loci. The original SunTag system consists of ten copies of the GCN4 peptide separated by 5-amino-acid linkers. To achieve efficient recruitment of an anti-GCN4 scFv fused to the ten-eleven (TET) 1 hydroxylase, an enzyme that demethylates DNA, we changed the linker length to 22 amino acids.

Entities:  

Keywords:  DNA methylation; Epigenetic editing; SunTag; TET1; dCas9

Mesh:

Substances:

Year:  2018        PMID: 29524149     DOI: 10.1007/978-1-4939-7774-1_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Bisphenol A and 17α-ethinylestradiol-induced transgenerational differences in expression of osmoregulatory genes in the gill of medaka (Oryzias latipes).

Authors:  Xuegeng Wang; Diamond Hill; Donald E Tillitt; Ramji K Bhandari
Journal:  Aquat Toxicol       Date:  2019-04-08       Impact factor: 4.964

Review 2.  Innovative Precision Gene-Editing Tools in Personalized Cancer Medicine.

Authors:  Xiaofeng Dai; Pilar Blancafort; Peiyu Wang; Agustin Sgro; Erik W Thompson; Kostya Ken Ostrikov
Journal:  Adv Sci (Weinh)       Date:  2020-04-23       Impact factor: 16.806

3.  Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells.

Authors:  Yuxi Chen; Jiaqi Liu; Shengyao Zhi; Qi Zheng; Wenbin Ma; Junjiu Huang; Yizhi Liu; Dan Liu; Puping Liang; Zhou Songyang
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

Review 4.  DNA Hypermethylation and Unstable Repeat Diseases: A Paradigm of Transcriptional Silencing to Decipher the Basis of Pathogenic Mechanisms.

Authors:  Loredana Poeta; Denise Drongitis; Lucia Verrillo; Maria Giuseppina Miano
Journal:  Genes (Basel)       Date:  2020-06-22       Impact factor: 4.096

5.  Genome-wide DNA hypermethylation opposes healing in patients with chronic wounds by impairing epithelial-mesenchymal transition.

Authors:  Kanhaiya Singh; Yashika Rustagi; Ahmed S Abouhashem; Saba Tabasum; Priyanka Verma; Edward Hernandez; Durba Pal; Dolly K Khona; Sujit K Mohanty; Manishekhar Kumar; Rajneesh Srivastava; Poornachander R Guda; Sumit S Verma; Sanskruti Mahajan; Jackson A Killian; Logan A Walker; Subhadip Ghatak; Shomita S Mathew-Steiner; Kristen E Wanczyk; Sheng Liu; Jun Wan; Pearlly Yan; Ralf Bundschuh; Savita Khanna; Gayle M Gordillo; Michael P Murphy; Sashwati Roy; Chandan K Sen
Journal:  J Clin Invest       Date:  2022-09-01       Impact factor: 19.456

6.  Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.

Authors:  Nozomi Hanzawa; Koshi Hashimoto; Xunmei Yuan; Kenichi Kawahori; Kazutaka Tsujimoto; Miho Hamaguchi; Toshiya Tanaka; Yuya Nagaoka; Hiroshi Nishina; Sumiyo Morita; Izuho Hatada; Tetsuya Yamada; Yoshihiro Ogawa
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.